Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Clinical trial NCT03082534 · COMPLETED

Trial details

NCT number: NCT03082534
Sponsor: University of California, San Diego
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HNSCC Lip SCC Oral Cavity Cancer Oropharynx Cancer Larynx Cancer Hypopharynx Cancer Nasopharynx Cancer Sinonasal Carcinoma Cutaneous Squamous Cell Carcinoma Head and Neck Neoplasms Head and Neck Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2017-03-28
Primary completion: 2025-07-21
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.